{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,16]],"date-time":"2026-11-16T05:35:13Z","timestamp":1794807313237,"version":"4.9.1"},"reference-count":23,"publisher":"Springer Science and Business Media LLC","issue":"12","license":[{"start":{"date-parts":[[2025,8,6]],"date-time":"2025-08-06T00:00:00Z","timestamp":1754438400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2025,8,6]],"date-time":"2025-08-06T00:00:00Z","timestamp":1754438400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"Hyogo Health Foundation subsidies"},{"name":"Japan Agency for Medical Research and Development grants","award":["24ek0109742h0001"],"award-info":[{"award-number":["24ek0109742h0001"]}]},{"DOI":"10.13039\/100019084","name":"Kobe University","doi-asserted-by":"crossref","id":[{"id":"10.13039\/100019084","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Clin Exp Nephrol"],"published-print":{"date-parts":[[2025,12]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Increased serum anti-nephrin antibody titers and co-localization of nephrin and IgG in kidney tissues have been reported in minimal change disease (MCD) and post-transplant recurrent focal segmental glomerulosclerosis (FSGS). These results indicate an association of anti-nephrin antibodies with nephrotic syndrome (NS); however, the exact relationship remains unclear. Herein, we evaluated nephrin\/IgG co-localization in the glomeruli of patients with various kidney diseases, including monogenic NS, to clarify the association between idiopathic nephrotic syndrome (INS) and anti-nephrin antibodies.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>\n                      IgG and nephrin co-localization was investigated in 52 kidney tissue biopsy samples, comprising INS in the active phase (\n                      <jats:italic>n<\/jats:italic>\n                      \u2009=\u200926; MCD,\n                      <jats:italic>n<\/jats:italic>\n                      \u2009=\u200919; FSGS,\n                      <jats:italic>n<\/jats:italic>\n                      \u2009=\u20097) and remission (\n                      <jats:italic>n<\/jats:italic>\n                      \u2009=\u20096), monogenic NS (\n                      <jats:italic>n<\/jats:italic>\n                      \u2009=\u20093), and other kidney diseases (\n                      <jats:italic>n<\/jats:italic>\n                      \u2009=\u200917). Double-immunofluorescence staining for nephrin\/IgG was performed in unfixed frozen sections for 2\u00a0h at room temperature with Alexa Fluor-labeled nephrin\/IgG cocktail antibodies. Nephrin\/IgG co-localization was assessed using optical sectioning under a fluorescence microscope.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>Nephrin\/IgG co-localization was observed in 81% (21\/26, children: 15\/17, adults: 6\/9) of active INS cases, 84% (16\/19) of MCD cases, and 71% (5\/7) of FSGS cases. No co-localization was observed in NS with monogenic variants or other kidney diseases.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>\n                      Nephrin\/IgG co-localization in the kidney tissue is finding observed in active INS\n                      <jats:bold>,<\/jats:bold>\n                      strongly indicating an association between anti-nephrin antibodies and INS onset. The nephrin\/IgG cocktail antibody is a rapid and effective approach for investigating INS pathogenesis that facilitates the differential diagnosis of immune-mediated NS from other kidney diseases, including monogenic NS.\n                    <\/jats:p>\n                  <\/jats:sec>","DOI":"10.1007\/s10157-025-02741-5","type":"journal-article","created":{"date-parts":[[2025,8,6]],"date-time":"2025-08-06T06:27:00Z","timestamp":1754461620000},"page":"1821-1828","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":8,"title":["Co-localization of IgG with nephrin in immune-mediated idiopathic nephrotic syndrome"],"prefix":"10.1007","volume":"29","author":[{"given":"Yuta","family":"Ichikawa","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nana","family":"Sakakibara","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shuhei","family":"Aoyama","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuka","family":"Kimura","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuta","family":"Inoki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yu","family":"Tanaka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chika","family":"Ueda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hideaki","family":"Kitakado","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"China","family":"Nagano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tomohiko","family":"Yamamura","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shingo","family":"Ishimori","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuko","family":"Shima","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hayaki","family":"Okamoto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hideki","family":"Fujii","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hironobu","family":"Maruyama","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kazumoto","family":"Iijima","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kandai","family":"Nozu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1655-6030","authenticated-orcid":false,"given":"Tomoko","family":"Horinouchi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,8,6]]},"reference":[{"key":"2741_CR1","doi-asserted-by":"publisher","first-page":"809","DOI":"10.1016\/S1097-2765(00)80057-X","volume":"1","author":"M Kestil\u00e4","year":"1998","unstructured":"Kestil\u00e4 M, Lenkkeri U, M\u00e4nnikk\u00f6 M, Lamerdin J, McCready P, Putaala H, et al. Positionally cloned gene for a novel glomerular protein\u2013nephrin\u2013is mutated in congenital nephrotic syndrome. Mol Cell. 1998;1:809\u201324.","journal-title":"Mol Cell"},{"key":"2741_CR2","doi-asserted-by":"publisher","DOI":"10.1038\/s41572-020-0196-7","volume":"6","author":"JB Kopp","year":"2020","unstructured":"Kopp JB, Anders HJ, Susztak K, Podest\u00e0 MA, Remuzzi G, Hildebrandt F, et al. Podocytopathies. Nat Rev Dis Primers. 2020;6: 68.","journal-title":"Nat Rev Dis Primers"},{"key":"2741_CR3","doi-asserted-by":"publisher","first-page":"556","DOI":"10.1016\/S0140-6736(74)91880-7","volume":"2","author":"RJ Shalhoub","year":"1974","unstructured":"Shalhoub RJ. Pathogenesis of lipoid nephrosis: a disorder of T-cell function. Lancet. 1974;2:556\u201360.","journal-title":"Lancet"},{"key":"2741_CR4","doi-asserted-by":"publisher","first-page":"2115","DOI":"10.2215\/CJN.03800609","volume":"5","author":"ET McCarthy","year":"2010","unstructured":"McCarthy ET, Sharma M, Savin VJ. Circulating permeability factors in idiopathic nephrotic syndrome and focal segmental glomerulosclerosis. Clin J Am Soc Nephrol. 2010;5:2115\u201321.","journal-title":"Clin J Am Soc Nephrol"},{"key":"2741_CR5","doi-asserted-by":"publisher","first-page":"207","DOI":"10.1007\/s00467-015-3082-x","volume":"31","author":"JC Davin","year":"2016","unstructured":"Davin JC. The glomerular permeability factors in idiopathic nephrotic syndrome. Pediatr Nephrol. 2016;31:207\u201315.","journal-title":"Pediatr Nephrol"},{"key":"2741_CR6","doi-asserted-by":"publisher","first-page":"809","DOI":"10.1016\/S0140-6736(23)01051-6","volume":"402","author":"M Vivarelli","year":"2023","unstructured":"Vivarelli M, Gibson K, Sinha A, Boyer O. Childhood nephrotic syndrome. Lancet. 2023;402:809\u201324.","journal-title":"Lancet"},{"key":"2741_CR7","doi-asserted-by":"publisher","first-page":"238","DOI":"10.1681\/ASN.2021060794","volume":"33","author":"AJB Watts","year":"2022","unstructured":"Watts AJB, Keller KH, Lerner G, Rosales I, Collins AB, Sekulic M, et al. Discovery of autoantibodies targeting nephrin in minimal change disease supports a novel autoimmune etiology. J Am Soc Nephrol. 2022;33:238\u201352.","journal-title":"J Am Soc Nephrol"},{"key":"2741_CR8","doi-asserted-by":"publisher","first-page":"337","DOI":"10.1007\/s00467-023-06107-5","volume":"39","author":"T Horinouchi","year":"2024","unstructured":"Horinouchi T, Nagano C, Watts AJB. Anti-nephrin antibodies in steroid-sensitive nephrotic syndrome in Japanese children. Pediatr Nephrol. 2024;39:337.","journal-title":"Pediatr Nephrol"},{"key":"2741_CR9","doi-asserted-by":"publisher","first-page":"422","DOI":"10.1056\/NEJMoa2314471","volume":"391","author":"FE Hengel","year":"2024","unstructured":"Hengel FE, Dehde S, Lass\u00e9 M, Zahner G, Seifert L, Schnarre A, et al. Autoantibodies targeting nephrin in podocytopathies. N Engl J Med. 2024;391:422\u201333.","journal-title":"N Engl J Med"},{"key":"2741_CR10","doi-asserted-by":"publisher","first-page":"608","DOI":"10.1016\/j.kint.2023.11.022","volume":"105","author":"Y Shirai","year":"2024","unstructured":"Shirai Y, Miura K, Ishizuka K, Ando T, Kanda S, Hashimoto J, et al. A multi-institutional study found a possible role of anti-nephrin antibodies in post-transplant focal segmental glomerulosclerosis recurrence. Kidney Int. 2024;105:608\u201317.","journal-title":"Kidney Int"},{"key":"2741_CR11","doi-asserted-by":"publisher","first-page":"1529","DOI":"10.1007\/s00467-020-04519-1","volume":"35","author":"A Trautmann","year":"2020","unstructured":"Trautmann A, Vivarelli M, Samuel S, Gipson D, Sinha A, Schaefer F, et al, International Pediatric Nephrology Association. IPNA clinical practice recommendations for the diagnosis and management of children with steroid-resistant nephrotic syndrome. Pediatr Nephrol. 2020;35:1529\u201361.","journal-title":"Pediatr Nephrol"},{"key":"2741_CR12","doi-asserted-by":"publisher","first-page":"881","DOI":"10.1007\/s10157-018-1534-x","volume":"22","author":"C Nagano","year":"2018","unstructured":"Nagano C, Nozu K, Morisada N, Yazawa M, Ichikawa D, Numasawa K, et al. Detection of copy number variations by pair analysis using next-generation sequencing data in inherited kidney diseases. Clin Experiment Nephrol. 2018;22:881\u20138.","journal-title":"Clin Experiment Nephrol"},{"key":"2741_CR13","doi-asserted-by":"publisher","first-page":"3497","DOI":"10.1007\/s00467-024-06468-5","volume":"39","author":"Y Ichikawa","year":"2024","unstructured":"Ichikawa Y, Sakakibara N, Nagano C, Inoki Y, Tanaka Y, Ueda C, et al. In steroid-resistant nephrotic syndrome that meets the strict definition, monogenic variants are less common than expected. Pediatr Nephrol. 2024;39:3497\u2013503.","journal-title":"Pediatr Nephrol"},{"key":"2741_CR14","doi-asserted-by":"publisher","first-page":"405","DOI":"10.1038\/gim.2015.30","volume":"17","author":"S Richards","year":"2015","unstructured":"Richards S, Aziz N, Bale S, Bick D, Das S, Gastier-Foster J, et al. Standards and guidelines for the interpretation of sequence variants: a joint consensus recommendation of the American college of medical genetics and genomics and the association for molecular pathology. Genet Med. 2015;17:405\u201324.","journal-title":"Genet Med"},{"key":"2741_CR15","doi-asserted-by":"publisher","first-page":"2008","DOI":"10.1681\/ASN.2022010070","volume":"33","author":"I Hada","year":"2022","unstructured":"Hada I, Shimizu A, Takematsu H, Nishibori Y, Kimura T, Fukutomi T, et al. A novel mouse model of idiopathic nephrotic syndrome induced by immunization with the podocyte protein Crb2. J Am Soc Nephrol. 2022;33:2008\u201325.","journal-title":"J Am Soc Nephrol"},{"key":"2741_CR16","doi-asserted-by":"publisher","first-page":"1124","DOI":"10.1016\/j.kint.2024.09.006","volume":"106","author":"V Raglianti","year":"2024","unstructured":"Raglianti V, Angelotti ML, Cirillo L, Ravaglia F, Landini S, Palazzo V, et al. Anti-slit diaphragm antibodies on kidney biopsy identify pediatric patients with steroid-resistant nephrotic syndrome responsive to second-line immunosuppressants. Kidney Int. 2024;106:1124\u201334.","journal-title":"Kidney Int"},{"key":"2741_CR17","doi-asserted-by":"publisher","first-page":"440","DOI":"10.1016\/j.kint.2023.12.015","volume":"105","author":"M Vivarelli","year":"2024","unstructured":"Vivarelli M, Colucci M. Anti-nephrin antibodies in recurrence of focal segmental glomerulosclerosis: closer to discovering the Holy Grail? Kidney Int. 2024;105:440\u20132.","journal-title":"Kidney Int"},{"key":"2741_CR18","doi-asserted-by":"publisher","first-page":"517","DOI":"10.2188\/jea.JE20120033","volume":"22","author":"JW Chang","year":"2012","unstructured":"Chang JW, Tsai HL, Yang LY, Chen TJ. Epidemiology and predictors of end-stage renal disease in Taiwanese children with idiopathic nephrotic syndrome. J Epidemiol. 2012;22:517\u201322.","journal-title":"J Epidemiol"},{"key":"2741_CR19","doi-asserted-by":"publisher","first-page":"651","DOI":"10.1007\/s10157-016-1319-z","volume":"21","author":"K Kikunaga","year":"2017","unstructured":"Kikunaga K, Ishikura K, Terano C, Sato M, Komaki F, Hamasaki Y, et al. High incidence of idiopathic nephrotic syndrome in East Asian children: a nationwide survey in Japan (JP-SHINE study). Clin Exp Nephrol. 2017;21:651\u20137.","journal-title":"Clin Exp Nephrol"},{"key":"2741_CR20","doi-asserted-by":"publisher","first-page":"1040","DOI":"10.1007\/s004670100021","volume":"16","author":"PA McKinney","year":"2001","unstructured":"McKinney PA, Feltbower RG, Brocklebank JT, Fitzpatrick MM. Time trends and ethnic patterns of childhood nephrotic syndrome in Yorkshire. UK Pediatr Nephrol. 2001;16:1040\u20134.","journal-title":"UK Pediatr Nephrol"},{"key":"2741_CR21","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1007\/s004670050555","volume":"13","author":"T Srivastava","year":"1999","unstructured":"Srivastava T, Simon SD, Alon US. High incidence of focal segmental glomerulosclerosis in nephrotic syndrome of childhood. Pediatr Nephrol. 1999;13:13\u20138.","journal-title":"Pediatr Nephrol"},{"key":"2741_CR22","doi-asserted-by":"publisher","first-page":"1308","DOI":"10.1016\/j.kint.2020.05.029","volume":"98","author":"X Jia","year":"2020","unstructured":"Jia X, Yamamura T, Gbadegesin R, McNulty MT, Song K, Nagano C, et al. Common risk variants in NPHS1 and TNFSF15 are associated with childhood steroid-sensitive nephrotic syndrome. Kidney Int. 2020;98:1308\u201322.","journal-title":"Kidney Int"},{"key":"2741_CR23","doi-asserted-by":"publisher","first-page":"2481","DOI":"10.1038\/s41467-023-37985-w","volume":"14","author":"A Barry","year":"2023","unstructured":"Barry A, McNulty MT, Jia X, Gupta Y, Debiec H, Luo Y, et al. Multi-population genome-wide association study implicates immune and non-immune factors in pediatric steroid-sensitive nephrotic syndrome. Nat Commun. 2023;14:2481.","journal-title":"Nat Commun"}],"container-title":["Clinical and Experimental Nephrology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10157-025-02741-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10157-025-02741-5\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10157-025-02741-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,11,27]],"date-time":"2025-11-27T09:29:40Z","timestamp":1764235780000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10157-025-02741-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,8,6]]},"references-count":23,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2025,12]]}},"alternative-id":["2741"],"URL":"https:\/\/doi.org\/10.1007\/s10157-025-02741-5","relation":{},"ISSN":["1342-1751","1437-7799"],"issn-type":[{"value":"1342-1751","type":"print"},{"value":"1437-7799","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,8,6]]},"assertion":[{"value":"24 January 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 July 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 August 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Tomoko Horinouchi reports research funding from Otsuka Pharmaceutical Co., Ltd., Sysmex Corporation, and Zenyaku Kogyo Co., Ltd. Kazumoto Iijima\u00a0reports consulting fees from\u00a0Kyowa Kirin Co., Ltd., Novartis Japan, Chugai Pharmaceutical Co., Ltd., and Zenyaku Kogyo Co., Ltd.; research grants from Zenyaku Kogyo Co., Ltd. and Nippon Shinyaku Co., Ltd.; honoraria from Zenyaku Kogyo Co., Ltd. and Novartis Japan; a patent on the development of antisense nucleotides for exon skipping therapy in Alport syndrome; and serves as an associate editor of Pediatric Nephrology. Kandai Nozu reports lecture fees from Ono Pharmaceutical Co., Ltd., Astellas Pharma Inc., Novo Nordisk Pharmaceuticals Ltd., Alexion Pharmaceuticals, Inc., Sumitomo Pharma Co., Ltd., Sanofi S.A., Otsuka Pharmaceutical Co., Ltd., Daiichi Sankyo Company, Limited, and Miyarisan Pharmaceutical Co., Ltd.; grants from Zenyaku Kogyo Co., Ltd. and Torii Pharmaceutical Co., Ltd.; speakers bureaus from Sumitomo Pharma Co., Ltd., Chugai Pharmaceutical Co., Ltd., JCR Pharmaceuticals Co., Ltd., Sanofi S.A., Zenyaku Kogyo Co., Ltd., and Kyowa Kirin Co., Ltd.; a patent for developing exon skipping therapy for Alport syndrome patients; and serves as a member of advisory groups for Kyowa Kirin Co., Ltd., Toa Eiyo Ltd., Zenyaku Kogyo Co., Ltd., and Taisho Pharmaceutical Co., Ltd. All remaining authors have nothing to disclose.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"All procedures performed in studies involving human participants were carried out in accordance with the ethical standards of the Institutional Review Board of Kobe University Graduate School of Medicine (IRB approval number: B200376 and 301), as well as with the 1964 Helsinki Declaration and its later amendments or comparable ethical standards.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}},{"value":"Comprehensive written informed consent was obtained from all individual participants included in the study and\/or their guardians for use of residual biopsied kidney samples and patients\u2019 clinical data, before renal biopsy and genetic analysis. Consent for publication was not required, because the study was retrospective and previously stored kidney biopsy specimens were used for staining.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Informed consent"}}]}}